In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
We are very excited to launch our new website! Please take a few moments to click around and explore...